Year: 2022-23

Company: BioMarin Pharmaceuticals

Liaison(s): Jeanette Motzer

Improving the Quality, Management and Use of Master Data essential to bio-pharmaceutical operations. The project is expected to include: Identification, acquisition and monitoring process for quality metrics and business KPI’s associated with the development and use of our master data. Improvement of data attribute definition and management, including facilitation of a pilot for attributes associated with Planning. Possible contribution to retirement of obsolete items. Research and report on recommended best practices for master data governance. Enhancement of current manufacturing recipe end-to-end processes.